An Analysis of the Use of Animal Models in Predicting Human Toxicology and Drug Safety
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Animal use continues to be central to preclinical drug development, in spite of a lack of its demonstrable validity. The current nadir of new drug approvals and the drying-up of pipelines may be a direct consequence of this. To estimate the evidential weight given by animal data to the probability that a new drug may be toxic to humans, we have calculated Likelihood Ratios (LRs) for an extensive data set of 2,366 drugs, for which both animal and human data are available, including tissue-level effects and MedDRA Level 1-4 biomedical observations. This was done for three preclinical species (rat, mouse and rabbit), to augment our previously-published analysis of canine data. In common with our dog analysis, the resulting LRs show: a) that the absence of toxicity in the animal provides little or virtually no evidential weight that adverse drug reactions (ADRs) will also be absent in humans; and b) that, while the presence of toxicity in these species can add considerable evidential weight for human risk, the LRs are extremely inconsistent, varying by over two orders of magnitude for different classes of compounds and their effects. Therefore, our results for these additional preclinical species have important implications for their use in predicting human toxicity, and suggest that alternative methods are urgently required.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These metrics are independent of event prevalence and incorporate both sensitivity and specificity (Bailey et al., 2014; Bailey and Balls, 2019; Shreffler and Huecker, 2024).”
From A large-scale concordance study of toxicity findings across preclinical species and humans for small molecules and biologics (2026) · cites this paper as Bailey et al., 2014
In the citing paper
“This result is consistent with previous reports (Bailey et al., 2014; Clark, 2015; Clark and Steger-Hartmann, 2018).”
From A large-scale concordance study of toxicity findings across preclinical species and humans for small molecules and biologics (2026) · cites this paper as Bailey et al., 2014
Citations
Cites
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998) · JAMA · doi:10.1001/jama.279.15.1200 · Cited by 4,807
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Concordance of the toxicity of pharmaceuticals in humans and in animals
Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., et al. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1399 · Cited by 2,050 · cited 1×
“One notable study claimed a good concordance between animal and human toxicology (12), though neither the predictive nature of the animal data for humans, nor the evidential weight provided by those data, were addressed (28).”
BackgroundStatistics Notes: Diagnostic tests 2: predictive values
Altman, D. G., & Bland, J. M. (1994) · BMJ · doi:10.1136/bmj.309.6947.102 · Cited by 1,711
Can Animal Models of Disease Reliably Inform Human Studies?
van der Worp, H. B., Howells, D. W., Sena, E. S., Porritt, M. J., Rewell, S., O'Collins, V., & Macleod, M. R. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000245 · Cited by 1,354
Nelson, D. R., Zeldin, D. C., Hoffman, S. M., Maltais, L. J., Wain, H. M., & Nebert, D. W. (2004) · Pharmacogenetics · doi:10.1097/00008571-200401000-00001 · Cited by 1,027
Kilkenny, C., Parsons, N., Kadyszewski, E., Festing, M. F. W., Cuthill, I. C., Fry, D., Hutton, J., & Altman, D. G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007824 · Cited by 860
Refining clinical diagnosis with likelihood ratios
Grimes, D. A., & Schulz, K. F. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66422-7 · Cited by 828
Comparison of Treatment Effects between Animal Experiments and Clinical Trials: Systematic Review
Perel, P., Roberts, I., Sena, E., Wheble, P., Briscoe, C., Sandercock, P., Macleod, M., Mignini, L. E., Jayaram, P., & Khan, K. S. (2007) · BMJ · doi:10.1136/bmj.39048.407928.be · Cited by 827
Polymorphism of human cytochrome P450 enzymes and its clinical impact
Zhou, S.-F., Liu, J.-P., & Chowbay, B. (2009) · Drug Metabolism Reviews · doi:10.1080/03602530902843483 · Cited by 826
Research works printed but not linked: 13
- Anon., 2004, Official Journal of the European Union L136, 34
- Aithal G.P., 2010, ATLA, 38, 1
- Bailey J., 2013, ATLA, 41, 335
- Anon. (2012). Likelihood Ratios. Oxford, UK: Centre for Evidence Based Medicine (CEBM). Available at: http://www.cebm.net/index.aspx?o=1043 (Accessed 28.05.13).
- CAAT–Europe, 2011, Centre for Alternatives to Animal Testing–Europe Workshop, 21–23 June 2011
- CAAT, 2011, Centre for Alternatives to Animal Testing Workshop
- Bailey J., 2008, ATLA, 36, 718
- SpanhaakS., CookD., BarnesJ. & ReynoldsJ. (2008). Species Concordance for Liver Injury, 6pp. Cambridge, UK: Biowisdom Ltd. Available at: http://www.biowisdom.com/files/SIP_Board_Species_Concordance.pdf (Accessed 28.05.14).
- BarnesJ.C., MatisS., KennaG., SwintonJ., BradleyP.M., DayN.C., ReedJ.Z., ReynoldsJ. & CookD. (2008). The Safety Intelligence Program: An Intelligence Network for Drug-induced Liver Injury, 2pp. Cambridge, UK: Biowisdom Ltd. Available at: http://bioblog.instem.com/downloads/Carboxylic_acids_A4.pdf (Accessed 28.05.14).
- Schott G., 2010, Deutsches Arzteblatt International, 107, 279
- Anon., 2010, Official Journal of the European Union L276, 33
- Anon. (1990). FDA Drug Review: Post Approval Risks 1976–1985. GAO/PEMD-90-15, 132pp. Washington, DC, USA: US General Accounting Office.
- Committee on Toxicity Testing and Assessment of Environmental Agents, National Research Council (2007). Toxicity Testing in the 21st Century: A Vision and a Strategy, 216pp. Washington, DC, USA: National Academies Press.
Cited by
Limitations of Animal Studies for Predicting Toxicity in Clinical Trials
Van Norman, G. A. (2019) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2019.10.008 · Cited by 732
“Furthermore, even in the presence of animal toxicity, LRs were extremely inconsistent and varied considerably for different classes of drugs (13,52).”
BackgroundBender, A., & Cortés-Ciriano, I. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.12.009 · Cited by 405
STopTox: An in Silico Alternative to Animal Testing for Acute Systemic and Topical Toxicity
Borba, J. V. B., Alves, V. M., Braga, R. C., Korn, D. R., Overdahl, K., Silva, A. C., Hall, S. U. S., Overdahl, E., Kleinstreuer, N., Strickland, J., et al. (2022) · Environmental Health Perspectives · doi:10.1289/ehp9341 · Cited by 215
New approach methodologies (NAMs): identifying and overcoming hurdles to accelerated adoption
Sewell, F., Alexander-White, C., Brescia, S., Currie, R. A., Roberts, R., Roper, C., Vickers, C., Westmoreland, C., & Kimber, I. (2024) · Toxicology Research · doi:10.1093/toxres/tfae044 · Cited by 213
The multifactorial role of the 3Rs in shifting the harm-benefit analysis in animal models of disease
Graham, M. L., & Prescott, M. J. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.040 · Cited by 195
Metadata
- Authors
- Bailey, J., Thew, M., & Balls, M.
- Affiliations
- British Union for the Abolition of Vivisection (BUAV), London, UK
- Fund for the Replacement of Animals in Medical Experiments (GB)
- Corresponding author
- Bailey, Jarrod
- ORCID
- Bailey, Jarrod
- Venue
- Alternatives to Laboratory Animals
- Publisher
- SAGE Publications
- Published
- 2014-06
- Volume
- 42
- Issue
- 3
- Pages
- 181-199
- ISSN
- 0261-1929 (ISSN-L)
- 2632-3559
- OpenAlex
- W2185365308
- Cited by
- 182
- References
- 57
- Citations by year
- 2026: 24 · 2025: 19 · 2024: 15 · 2023: 25 · 2022: 20 · 2021: 15 · 2020: 23 · 2019: 18 · 2018: 11 · 2017: 4 · 2016: 5 · 2015: 1 · 2014: 2
- FWCI
- 5.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Alternatives to Laboratory Animals (publishedVersion)
- PubMed (publishedVersion)
- WBI Studies Repository (submittedVersion)
- Topics
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- animal models, preclinical drug development, likelihood ratios, drug safety, adverse drug reactions, rats, mice, rabbits, evidential weight, alternative methods, MedDRA
- MeSH terms
- Animals, Drug Evaluation, Preclinical, Humans, Rabbits, Toxicology, Models, Animal, Animal Experimentation, Mice, Rats, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An Analysis of the Use of Animal Models in Predicting Human Toxicology and Drug Safety. https://app.cochat.ai/papers/10.1177/026119291404200306
- The paper
- Bailey, J., Thew, M., & Balls, M. (2014). An Analysis of the Use of Animal Models in Predicting Human Toxicology and Drug Safety. Alternatives to Laboratory Animals. https://doi.org/10.1177/026119291404200306
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.